Krebs Biochemicals & Industries Ltd.
| BSE: 524518 | Sector: Health care |
| NSE: KREBSBIO | ISIN Code: INE268B01013 |
| BSE 12:04 | 22 Sep | 200.05 |
4.05 (2.07%) |
OPEN
204.00 |
HIGH
207.15 |
LOW
192.85 |
| NSE 11:54 | 22 Sep | 200.00 |
3.60 (1.83%) |
OPEN
200.00 |
HIGH
207.00 |
LOW
192.50 |
| OPEN | 204.00 |
| PREVIOUS CLOSE | 196.00 |
| VOLUME | 22359 |
| 52-Week high | 207.15 |
| 52-Week low | 81.50 |
| P/E | |
| Mkt Cap.(Rs cr) | 431 |
| Buy Price | 199.65 |
| Buy Qty | 19.00 |
| Sell Price | 200.15 |
| Sell Qty | 42.00 |
Krebs Biochemicals & Industries Ltd. (KREBSBIO) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 727.05 | 0.70 | 0.10 | 3112.91 |
| Cipla | 965.50 | 9.45 | 0.99 | 2468.28 |
| Dr Reddy's Labs | 4831.90 | -22.95 | -0.47 | 2186.40 |
| Sun Pharma.Inds. | 769.00 | 4.45 | 0.58 | 2139.70 |
| Divi's Lab. | 5155.00 | -23.85 | -0.46 | 1954.72 |
| Alkem Lab | 3863.20 | 2.75 | 0.07 | 1685.08 |
| Glenmark Pharma. | 513.10 | 6.95 | 1.37 | 1649.45 |
| Cadila Health. | 557.25 | 7.10 | 1.29 | 1476.20 |
| Lupin | 939.30 | 9.50 | 1.02 | 1258.62 |
| Alembic Pharma | 803.80 | 22.55 | 2.89 | 1175.39 |
| Ipca Labs. | 2429.35 | -4.55 | -0.19 | 1140.77 |
| Torrent Pharma. | 3071.40 | 28.30 | 0.93 | 1137.85 |
| Gland Pharma | 3872.00 | 11.20 | 0.29 | 997.01 |
| Laurus Labs | 620.45 | -3.40 | -0.55 | 956.11 |
| Abbott India | 21304.15 | 511.60 | 2.46 | 690.69 |
| Ajanta Pharma | 2181.85 | 6.00 | 0.28 | 675.64 |
| Wockhardt | 430.55 | 6.05 | 1.43 | 593.29 |
| Granules India | 323.15 | 1.45 | 0.45 | 552.78 |
| Pfizer | 5800.00 | 5.40 | 0.09 | 497.61 |
| Sanofi India | 8039.80 | 225.60 | 2.89 | 477.60 |
Quick Links for Krebs Biochemicals & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
